Paul is a 30-year veteran driving business development in biotech, specialising in in vitro diagnostics for infectious diseases. Hs is an Australian representative for Geneva-based Global Antibiotic R&D partnership (GARDP), member of the Investment Committee at Horizon 3 Biotech Fund, and strategic advisor to Alsonex, Marinova and other Australian biotech companies. Prior he was the Life Sciences Senior Investment Specialist at Australian trade and investment agency, Austrade.
